Ionic modulators of stem cell state by Omelyanenko, Anna
  
From DEPARTMENT OF PHYSIOLOGY AND 
PHARMACOLOGY 
Karolinska Institutet, Stockholm, Sweden 
IONIC MODULATORS OF STEM CELL 
STATE 
Anna Omelyanenko 
 
Stockholm 2016 
 
  
 
All previously published papers were reproduced with permission from the publisher.  
Published by Karolinska Institutet. 
Printed by AJ E-print AB 
© Anna Omelyanenko, 2016 
ISBN 978-91-7676-286-8 
  
Ionic Modulators of Stem Cell State 
THESIS FOR DOCTORAL DEGREE (Ph.D.) 
By 
Anna Omelyanenko 
Principal Supervisor: 
Assistant Professor Michael Andäng 
Karolinska Institutet 
Department of Physiology and Pharmacology 
Division of Pharmacology 
 
Co-supervisor(s): 
Dr. Helena Johard 
Karolinska Institutet 
Department of Physiology and Pharmacology 
Division of Pharmacology 
 
Dr. Gabriella Lundkvist 
Karolinska Institutet 
Department of Neuroscience 
 
Prof. Per Uhlen 
Karolinska Institutet 
Department of Biochemistry and Biophysics 
Division of Molecular Neurobiology 
 
Opponent: 
Professor Hans-Georg Kuhn 
University of Gothenburg 
Department of Clinical Neuroscience 
 
Examination Board: 
Assistant Professor Anna Falk 
Karolinska Institutet 
Department of Neuroscience 
 
Professor Finn Hallböök 
Uppsala University 
Department of Neuroscience 
Division of Developmental Neuroscience 
 
Associate Professor Erik Sundström 
Karolinska Institutet 
Department of Neurobiology, Care Sciences and 
Society 
Division of Neurodegeneration 
 
 
  
 
 
To new beginnings  
  
 
 
  
ABSTRACT 
Tissue generation during development and maintenance throughout life relies on the 
proliferation and sequential specification of a group of cells. Stem cells are defined by the 
properties of self-renewal (division to produce daughter cells equipotent to the mother) and 
differentiation (division where at least one daughter is of a more restricted potential). In 
adult systems, two additional states - quiescence, a dormant state of infrequent 
proliferation, and activation, a state of increased proliferation, are described. Regulation of 
these states is a key determinant of health and fitness on a tissue and organism level, as it 
ensures proper development and regeneration. The aim of this thesis is to investigate how 
another key system at the cellular level – regulation of ion availability – can modulate cell 
states of embryonic and adult stem cells.  
In paper I the effect of lithium chloride (LiCl) on juvenile mouse neural stem progenitor 
cells (NSPCs) from the subgranular zone (SGZ) of the hippocampus was investigated. 
Under maintenance conditions, treatment with LiCl increased NSPC proliferation, reducing 
the fraction of cells in G0/G1. Pre-treatment of NSPCs with LiCl prior to ionizing radiation 
(IR) exposure reduced DNA damage response activation, and attenuated the IR-induced G1 
block, restoring proliferation, although cell death was not reduced. 
In paper II the effect of ZD7288, a specific blocker of hyperpolarization-activated cyclic 
nucleotide-gated (HCN) channels, on mouse embryonic stem cell (ESCs) was examined. 
The blocker attenuated proliferation by extending G1 and S phases. This did not 
compromise pluripotency, but facilitated spontaneous serum-induced differentiation while 
reducing the efficiency of directed differentiation towards the neuronal lineage.  
In paper III expression of HCN family channels and effects of their inhibition in adult 
NSPCs were described. Hcn2 and Hcn3 are expressed throughout the NSPC hierarchy, but 
only functional in S and G2/M phases. HCN inhibition or knockdown attenuated 
proliferation due to a reversible G0/G1 accumulation which was accompanied by 
alterations in activation marker expression, metabolism, and the molecular clock network. 
A small molecular agonist of Rev-erb-α, a clock component, recapitulated the proliferative 
effects. HCN inhibition-induced G0/G1 block was shown to have a protective effect during 
IR exposure of juvenile mice, reducing apoptosis and maintaining proliferation.  
In conclusion, lithium, which is proposed to inhibit a number of enzymes by replacing 
magnesium as a cofactor, and HCN currents, which are involved in regulation of the 
electrochemical state of the cell, were shown to modulate stem cell state. This suggests that 
further investigation of these and other ionic modulators is warranted, both for therapy 
development and in the interests of basic science. 
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1 INTRODUCTION 
1.1 THE STEM CELL PARADIGM 
We all start life as a single cell and end it as a multitude. From a single fertilised egg the 
many cell types found in the adult body emerge. This phenomenon represents a fundamental 
difference between uni- and multicellular organisms, yet the molecular mechanisms deciding 
cellular birth and death are remarkably similar from yeast to human. While the lifecycle of 
even a unicellular eukaryote, such as yeast, already allows access to a number of cell fates 
(division, mating, apoptosis), the increased complexity of multicellular life requires the 
introduction of additional fate states, at least in some cells. Today’s answer to this conceptual 
challenge is introduction of a category of cells with greater developmental potential than 
mature somatic cells – the so called stem cells. These are cells possessing the two properties 
essential for making development (embryonic stem cells) and maintenance (adult stem cells) 
of multicellular life as we observe it possible: self-renewal and differentiation
1
.  
Self-renewal is the property of dividing to give rise to two daughter cells of which at least one 
has the same developmental potential as the original cell. This ensures the possibility of 
maintaining the stem cells population (in case of asymmetric division) while increasing cell 
number, or even expanding the stem cell pool (in case of symmetric division to two cells 
equipotent to the mother cell). Although not every stem cell will undergo self-renewal every 
time, it is a cardinal property of stem cells that under the right conditions they may do so. 
This property is essentially no different from regular division of adult cells – a fibroblast that 
will always be a fibroblast may divide to give rise to two fibroblasts of the same potential, 
which also can divide to give rise to fibroblasts. What makes self-renewal different from 
simple division is its tie to the second cardinal property of stem cells: differentiation. 
Differentiation is the property of having the potential to give rise to cells with a 
developmental potential distinct from, and more restricted than that of the original cell. This 
allows first the creation of the germ layers and distinct lineages, and finally the generation of 
terminally differentiated cells, either capable of division or that have exited the cell cycle. 
These cells can then develop the distinct cell physiology that allows them to be best suited for 
their role in the tissue and the organism.   
1.1.1 Stem cells in regeneration: quiescent, active, and differentiated  
While embryonic stem cell lineages are generally a transient fate state, in organs with 
substantial cell turnover, life-long self-renewal and differentiation of a progenitor population 
 10 
is the primary source of new cells. This allows mature cells to be functionalized without 
compromising tissue turn over, since when the cells reach the end of their life cycle they are 
replaced through differentiation of newly divided cells higher up along the differentiation 
hierarchy. Studies of the blood system in adult mice were instrumental both in the initial 
definition and development of the stem cell paradigm. Many credit James Till and Earnest 
McCullough with the “discovery” of stem cells during their work on hematopoiesis2. Based 
on their findings that the blood system of a bone marrow-ablated host could be fully 
reconstituted, even in the long term, by some cells from the bone marrow of a donor, both the 
defining properties and the functional definition of stem cells in the blood system were 
formulated. Serving as a prototype in stem cell biology, the hematopoietic system is still one 
of the best understood and certainly most clinically relevant adult stem cell systems.  
Till and McCullough also reported equipotent cells that were long- or short-term repopulating 
based on the length of time during which they were able to sustain hematopoiesis. The long-
term repopulating cells were found to be label retaining, indicating low division frequency. 
This combination of high potency and low division frequency represents the state now 
commonly referred to as “quiescence”.  This concept is applicable in many adult stem cell 
systems and the quiescent and activated (proliferative) states are associated with expression 
or repression of particular genes. Well studied in the blood system, these genes, and even 
hematopoietic stem cell (HSC) properties, vary depending on the timing and location of 
hematopoiesis, indicating that stem cell state is an emergent property of intrinsic factors and 
environmental influence.   
Environmental factors (secreted and physical) that a stem cell experiences are often 
collectively called “the niche”. The niche is known to play an important role in regulating all 
aspects of stem cell behaviour. Both secreted and physical niche factors have been reported to 
regulate stem cell pool size
3
, and inherent proliferative properties. As an example, long-term 
repopulating HSCs in the liver, the site of fetal hematopoiesis in mammals, are more 
proliferative and express different surface markers than they do in the bone marrow, the site 
of adult hematopoiesis
4
.   Interestingly, the location of the HSC niche varies not only through 
development but also among species:  from kidney in fish, to bone marrow in birds. Perhaps 
most intriguingly, the HSC niche seasonally migrates between the bone marrow and the liver 
in some frogs
4,5
.  This diversity may reflect different functional requirements for the niche (e. 
g. accessibility of external cues, protection from damage), understanding which may be 
instrumental to mobilizing endogenous or using adult stem cells for therapy.   
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1.2 ADULT NEUROGENESIS 
The brain and the central nervous system (CNS) were long believed to exclusively be 
populated by non-proliferative cells, as there is no obvious ongoing turnover or need for 
regeneration, unlike in the blood system
6.  This was questioned extensively in the 1960’s, 
when  Altman and coworkers published a number of papers showing proliferation in the adult 
brain and providing evidence of neurogenesis in the mouse and other mammals
7-9
.  Evidence 
of adult neurogenesis in humans only became available in 1998, when Eriksson and 
coworkers published their work identifying dividing cells in the brains of cancer patients
10
. 
At present, the two neurogenic niches most extensively studied in mammalian brains are the 
subgranular zone (SGZ) of the hippocampus, and the subventricular zone (SVZ) (see Figure 
1) of the lateral ventricle, with ongoing controversy regarding the existence of additional 
niches
11
. Although proliferative activity is more abundant in the SVZ in the mouse
12
, both 
niches are populated by cells which undergo division and give rise to new neurons. The SGZ 
produces granule neurons and astrocytes for the dentate gyrus, whereas SVZ gives rise to 
oligodendrocytes and to neuroblasts that migrate along the rostral migratory stream, 
becoming olfactory bulb interneurons
13,14
. The dynamics of neurogenesis have also been 
investigated, and the number of dividing cells as well as newly born neurons was shown to 
decrease with age both in mice
15,16
  and humans
17
.    
 
Figure 1: Neurogenic zones in the mouse brain. Modified from Genes and Development, 26 
(10), Hsieh J, Orchestrating transcriptional control of adult neurogenesis, 1010-1021 (2012) 
under the Creative Commons license.   
Unlike in other adult tissues, the main role of the proliferative progenitor compartment in the 
brain appears to be facilitation of plasticity, rather than tissue maintenance and replacement 
of exhausted cells. On a cellular level new-born neurons in the adult brain possess electrical 
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properties unique from those of mature neurons and can thus code information differently
18
. 
On a tissue level, newly generated neurons form new synapses, modifying existing neural 
circuitry
19
. When looking at the level of cognitive function and behaviour in the mouse, 
neurogenesis contributes to both short- and long-term memory. Olfactory bulb neurogenesis 
is believed to be important for short-term memory and olfactory learning
20,21
, while 
neurogenesis in the hippocampus is important for long-term memory formation and pattern 
recognition
20,22
. Adult neurogenesis has also been suggested to be involved in mood 
regulation and hippocampal neurogenesis was shown to be necessary for function of a 
number of antidepressants
23,24
. Intriguingly, neurogenesis was also shown to be increased in 
response to damage, such as due to epileptic seizures
25
 and stroke
26
, in line with a more 
conventional role of tissue repair and regeneration for the neurogenic pool. 
With the homeostatic and potentially injury repair functions of adult neurogenesis in mind, a 
number of clinical interventions are possible. Transplantation or activation of endogenous 
neural precursors into an injured brain is a potential strategy. This has been tested in 
Parkinsonian patients who received fetal cell transplants
27
. Additionally, modulation of 
proliferation to affect mood disorders may in fact be current practice already, as a number of 
antidepressant therapies are hypothesized to function through inducing proliferation
28,29
.  In 
patients experiencing loss of neurogenic potential an alternative clinical strategy is 
preservation or enhancement of the proliferative pool to improve cognitive outcomes. This is 
particularly relevant for when the injury is a side effect of therapy, such as what is seen in 
treatment of pediatric brain cancers
30
. Adults who had suffered from brain cancer as children 
were found to have reduced neurocognitive abilities, with degree of impairment proportional 
to dose of radiation received
31
. Given that postnatal neurogenesis is highest at younger ages, 
it has been proposed that irreversible damage to the proliferating progenitor pool may 
underlie the impairments observed later in life
32
. Strategies to address this have included 
stimulating neurogenesis after the event
33
, as well as neuroprotective neoadjuvant 
treatments
34
, including the well-known mood stabilizer, lithium
35
.  
1.2.1 Stem cell hierarchy in the adult mouse brain 
Neural cells originate from the ectodermal layer of the embryo, which forms the neurotube 
made up by neuroepithelial cells, a symmetrically and rapidly dividing population of early 
neuronal progenitors.  Neuroepithelial cells are further specified to become radial glia cells, 
which continue to divide symmetrically, self-renewing until the onset of neurogenesis. As 
neurogenesis commences radial glia cells start to divide asymmetrically giving rise to 
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intermediate progenitor cells that go on to further differentiate to neurons. Following 
neurogenesis, gliogenesis is initiated, and when that nears its close, radial glia cells start to 
divide symmetrically, exhausting their pool
36,37
. Neurogenesis in gyrencephalic species (e.g. 
sheep, primates) involves additional intermediate cell types, necessary to build up the many 
cortical layers that are not found in the most commonly studied lissencephalic animals 
(mouse) discussed here
38
.  
It is not entirely clear which neurogenic cells in the embryonic developmental cascade give 
rise to adult neural stem progenitor cells (NSPCs). It has been suggested that SGZ NSPCs are 
generated late during gestation in the ventral hippocampus and migrate to their eventual 
location by birth
39
, whereas SVZ NSPCs are generated in situ and simply remain quiescent 
until the end of neurogenesis
40
.  Postnatally, the neurogenic cascade in the SVZ (see Figure 
2A) starts with the mostly quiescent, radial glia-like type B cells, located close to the 
ventricular wall projecting a cilium into the ventricle. These cells express the GFAP and stem 
cell marker SOX2 and persist over a long time. The transit-amplifying type C cells occupy 
the same niche, but are further away from the ventricle, proliferate much more, and give rise 
to type A cells, which are the migrating neuroblasts destined to become neurons
41
.  In the  
 
Figure 2: (A) In the SVZ 
NSPC hierarchy starts with 
type B cells, transit amplifying 
type C cells, and type A 
neuroblasts. (B) in the SGZ 
radial type I are followed by 
transit amplifying type II cells 
and type 3 neuroblasts. 
Modified from Genes and 
Development, 26 (10), Hsieh J, 
Orchestrating transcriptional 
control of adult neurogenesis, 
1010-1021 (2012) under the 
Creative Commons license. 
 
 
 
SGZ (see Figure 2B), type I cells represent the main progenitor population and, similar to 
radial glia during embryonic neurogenesis, have projections spanning the entire granule cell 
layer. Like type B cells in the SVZ, they express GFAP as well as SOX2. There are also type 
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II cells that are less similar to radial glia than type I cells, due to lack of GFAP expression and 
a shortened morphology, but that still express SOX2. There is significant debate regarding 
their identity in relation to type I cells, with some arguing that they are more restricted 
progeny, while others believe the two cell types represent interconvertible pools
19,42
. Finally, 
the SGZ also contain intermediate progenitors that undergo symmetrical division to give rise 
to neural cells without further proliferative potential
43
.  Currently, identification of the various 
NSPC types relies on their position and morphology in vivo, as well as expression of a 
number of characteristic markers, of which SOX2, GFAP, Prominin1, and Nestin are 
associated with the most potent cell type (type B and type I). 
SVZ and SGZ NSPCs are usually isolated for in vitro culture as neurospheres, by dissecting 
out the relevant anatomical brain region, dissociating the tissue and growing the resulting cell 
in a defined media supplemented with fibroblast growth factor (FGF) and epidermal growth 
factor (EGF), which have been shown to support NSPC expansion. Bulk cultures from both 
neurogenic regions have been shown to exhibit stem cell properties, as they are self-renewing 
and multipotent, giving rise to neurons, astrocytes and oligodendrocytes in vitro
44,45
. In vitro 
differentiation of clonal SVZ-derived cells initially indicated bipotentiality only, with only 
neuronal and glial progeny observed
46
, and more recently, it has been suggested that clonally 
SVZ NSPC can only give rise to neurons
47
. This is in line with in vivo reports of single 
lineage differentiation of SVZ precursors, which also suggested their rapid exhaustion once 
proliferation is initiated
48
. Similar controversy applies to the SGZ, where there are reports of 
both exhaustion
49
 and cycling between active proliferation and quiescence
50
. These disparate 
findings leading to the use of the term “stem progenitor cell”, as they bring up the questions 
of whether NSPCs are bona fide stem cells very tightly controlled by their niche, or represent 
separate progenitor populations with limited stem cell potential. However, work showing that 
in vitro cultured SGZ NSPCs give rise to SVZ-specific cell types in vivo
51
 when transplanted 
into the SVZ argues for the former.  
1.2.2 Cell cycle in NSPCs 
Cell cycle control in NSPCs involves the canonical cell cycle machinery and follows the 
usual order of G1-S-G2-M, but with a prominent G0, especially in vivo.  While G0 is the 
quiescent phase when cells are neither undergoing not preparing for division, G1 and G2 are 
growth phases when the cells are preparing for DNA synthesis and for cell division, 
respectively. The entire process is regulated by sequential activation of cyclin-dependent 
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kinases (CDKs) and transcription of specific genes, and involves three checkpoints, at G1/S 
transition, in G2, and in M phase (see Figure 3). 
 
Figure 3: Cyclical activity of cyclins and CDKs regulates progression of somatic cells 
through the cell cycle. Reprinted from Current topics in developmental biology, 104, 
Tsubouchi T, Fisher A. Reprogramming and the Pluripotent Stem Cell Cycle. 223-241 (2013) 
with permission from Elsevier. 
Cyclins D (D1/D2/D3) are regulated by mitogen signalling and together with CDK4 and 6 
regulate G1 progression by phosphorylating the retinoblastoma protein (Rb), releasing it from 
binding E2F. Once sufficient E2F is available, cyclins E and A are transcribed and the cell 
cycle proceeds when cyclin E-CDK2 phosphorylation of Rb reaches critical levels, passing 
the so called “restriction point” and committing the cell to division. CDK2 then cooperates 
with cyclin A to phosphorylate DNA synthesis machinery as the S-phase progresses. With the 
end of S-phase, CDK2 is replaced with CDK1, which cooperates with cyclin A and the G2/M 
cyclin B to phosphorylate G2/M targets. Once the M-phase is complete and the cell has 
divided, the cell cycle machinery is reset to the start and cyclin D starts to build up in 
response to mitogen signalling, if cycling is continuous. The activity of CDKs is regulated 
not only by the availability of cyclins, but also by their subcellular localization, degradation, 
and inhibition by cyclin-dependent kinase inhibitor proteins (CKIs). CKIs include INK4 
proteins (p15, p16, p18, and p19) that regulate CDK4 and 6 activity and G1 progression, and 
the Cip/Kip family (p21,p27,p57) that regulate CDK activity in both G1 and G2, and DNA 
synthesis directly (in the case of p21)
52,53
.   
Expression of CKIs is most notably regulated by p53, which is upregulated in response to 
DNA damage and is the main effector in the G1 DNA damage checkpoint. In response to 
DNA damage during G1, p53 upregulates CKI expression, preventing G1/S progression and 
inducing G1 arrest.  It can also play a role in G2 DNA damage response, where p53-induced 
p21 expression can inhibit CDK1. G2/M progression is abrogated if DNA damage is present 
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even in the absence of p53, due to the action of checkpoint kinases 1 and 2 (Chk1 and Chk2).  
Cell cycle stalling in response to DNA damage allows repair or induction of apoptosis to 
safeguard genomic integrity in the daughter cells, and is regulated by the ataxia telangiectasia 
mutated (ATM) and Rad3-related (ATR) proteins. The final checkpoint is the mitotic spindle 
checkpoint in the M-phase, which ensures correct chromosomal segregation during division. 
If the mitotic spindle and chromosomes are not correctly assembled, the cells stall due to 
mitotic arrest deficient 2 (Mad2)-mediated inhibition of cell-division cycle protein 20 
(Cdc20), resulting in inhibition of the anaphase-promoting complex (APC/C), which would 
otherwise be driving the cell cycle forward by ubiquitination and degradation of cell cycle 
machinery
52,54
.  
1.2.3 Quiescence and activation in NSPCs 
The more intriguing and unique aspect of NSPC cell cycle regulation is the regulation of 
G0/G1 balance. Early studies examining neurogenesis in the adult brain using anti-mitotic 
drug identified that the majority of NSPCs in vivo are quiescent in the G0 cell cycle phase
41
. 
Recent reports are suggesting that although not mitotically active, quiescence is not a passive 
state and presence of signalling is necessary for its maintenance
55
. WNT signalling has been 
shown to regulate quiescence
56, as does γ-aminobutyric acid (GABA) signalling through the 
GABAA receptor, the absence of which resulted in NSPC reactivation following irradiation 
injury
57,58
. Prominin1, a hallmark of NSPCs, is expressed in primary cilia, known for acting 
as signalling centres, and is also characteristic of quiescence
59
. In fact, Prominin1 expression 
coupled with lack of epidermal growth factor receptor (EGFR) expression is commonly used 
to identify quiescent cells
60
, with the absence of EGFR highlighting their low dependence on 
mitogens.   
In line with this, quiescent cells have been shown to have altered metabolic requirements
61
, 
be resistant to mitochondrial perturbations
62
 and have gene expression signatures consistent 
with glycolytic metabolism
63
.  A number of cell-intrinsic parameters, such as expression of 
lineage-related transcription factors (SOX2, REST
64
, OLIG2
65
, ASCL1
66
), the nuclear 
receptor TLX 
67
, circadian regulator PER2
68
, epigenetic modifiers (NFIX
69
, DNMT3a
70
), and 
cell cycle machinery (CHD7
71
, p27
72
) have been linked to regulation of the stem cell pool and 
the balance between quiescence and activation. Niche factors such as growth factor signaling 
through FGF2 and bone morphogenic protein 4 (BMP4)
73
 and vascular contact
74
 have also 
been implicated in maintenance of quiescence and activation. Unfortunately, the mechanisms 
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of interconversion between the two pools and, in particular of quiescence induction, are still 
poorly understood, highlighting the need for further study. 
1.3 EMBRYONIC STEM CELLS 
Mouse embryonic stem cells (ESCs) were first isolated and cultured in 1981 from the inner 
cell mass of the preimplantation blastocyst at embryonic day 3.5 (E3.5), or the epiblast at 
E4.5, and represent cells of the late pre-implantation blastocyst
75
 (see Figure 4). A similar cell 
type can be derived from early human pre-implantation blastocysts that are the by-product of 
in vitro fertilization, although these cells represent a developmentally distinct cell type. In 
normal development, ESCs give rise to the three embryonic germ layers – mesoderm, 
endoderm, and ectoderm, making all the adult tissues of embryonic origin. In vitro, they can 
be maintained indefinitely (as they express telomerase and are not subject to telomere 
shortening) without losing their stem cell properties, provided they are cultured under 
permissive conditions.  
 
Figure 4: Early development of the mouse. Embryonic stem cells are derived from and 
correspond to E3.5 or E4.5 the pre-implantation blastocyst.  Reprinted from Current topics in 
developmental biology, 107, Posfai E, Tam OH, Rossant J. Mechanisms of pluripotency in 
vivo and in vitro. 1-37 (2014) with permission from Elsevier. 
The ability of ESCs to be cultured long term is remarkable not only because they are not 
transformed, but also because unlike adult stem cells, which persist for many years in vivo, 
they usually represent a very transient state in mouse development. An exception exists in 
diapause – a facultative stalling of mouse embryo development at an about 130 cell stage 
induced by metabolic restriction, such as lactation of the mother
76
. At this time, metabolic 
processes such as glycolysis, in the cells of the blastocyst are downregulated
77
, and autophagy 
has been proposed to take place in some cells to generate nutrients for the others
78
. The 
process is proposed to be regulated by microRNAs
79
 and results in G0/G1 stalling
80
 and 
major alterations in cell metabolism
76
, resembling quiescence of adult stem cells. Recent 
work comparing transcriptional profiles of diapaused and developing blastocysts has in fact 
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identified E4.5 as the active stage most similar to that seen in the diapaused epiblast
81
, 
suggesting that in vitro cultured ESCs should also be capable of reaching the diapaused state, 
but the conditions necessary for reaching it are only just beginning to be described. 
ESC are fascinating for many reasons, not the least of which being their extensive 
proliferative capacity and ability to generate most mature cell types, given the proper 
inductive cues. As with many cell types, identification of conditions permissive of efficient in 
vitro maintenance and expansion is critical for allowing both basic and applied research using 
ESCs. Generation of knockout mice, which has become a cornerstone of biological research, 
has been based on ESC technology for many years now and is one example of the usefulness 
of ESC as tools. This process has been significantly facilitated by the development of defined 
culture methods, which use small molecule inhibitors to generate uniform populations of 
undifferentiated ESCs
82
. However, the final goal remains to develop this cell type for 
regenerative medicine. A decade ago a breakthrough in stem cell biology was made by the 
team of Shinya Yamanaka, who developed the technology for reverting mature cells to the 
ESC stage by induction of a set of key genes linked to ESC identity
83
, drawing this goal 
closer. However, clinical use of ESC-based technology will still require, at the very least, 
efficient and well-defined protocols for stem cell differentiation as well as culture, and 
adaption of them to human cells.  
1.3.1 Stemness and differentiation in embryonic stem cells 
Embryonic stem cell state is characterized by self-renewal and the ability to differentiate to 
all somatic cell types (pluripotency). As such, the gold-standard functional test to determine 
stem cell capacity in ESCs is aggregation with or injection into a developing blastocyst, 
which should result in chimeric embryos with ESC contribution to all germ layers. The key to 
ESC identity lies in the expression of the core pluripotency transcription factors: OCT3/4, 
SOX2, and NANOG. Expression of these genes endows ESCs with their characteristic 
properties: clonogenicity (ability of a single cell to give rise to a colony) and pluripotency 
(ability to give rise to cells of all embryonic germ layers). Insufficient expression of these 
genes, on the other hand, results in ESC differentiation even under maintenance conditions, 
and in the case of OCT3/4, even overexpression perturbs pluripotency
84
. These transcription 
factors function by regulating their own and each other’s expression, and cooperatively bind 
peripheral targets that are also involved in pluripotency maintenance, making the network 
even more robust. They also bind the promoters and repress the expression of differentiation 
inducers, such as GATA6 which drives the first in vivo differentiation event – the formation 
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of the primitive endoderm
85
. Conclusive proof of this is the ability of the core pluripotency 
factors to induce the ESC state in mature cells when overexpressed during the process of 
reprogramming, giving rise to induced pluripotent stem cells (iPSCs)
83
. This technology has 
been extended to human cells
86
, and has initiated discussions of comprehensive human 
leukocyte antigen (HLA)-based donor cell line biobanking initiatives that would provide 
nation-wide coverage and near-universal access to future stem-cell based therapies with 
minimal immunological complications
87
. 
Efficient maintenance of the pluripotent state in vitro was traditionally achieved by culture in 
media supplemented with leukemia inhibitory factor (LIF)
88
 and serum (with BMP4 believed 
to be the key molecule)
89
, that have more recently been replaced by two small molecule 
inhibitors: one targeting mitogen-activated protein kinase (MEK) and the other targeting 
glycogen synthase kinase 3 (GSK3)
82
. The role of MEK inhibition in this culture protocol is 
to inhibit FGF signalling, which is responsible for initiation of differentiation already at the 
level of the inner cell mass, where it is essential for giving rise to the differentiated hypoblast 
along with the pluripotent epiblast
90
.  FGF signalling is endogenous to ESCs, which produce 
FGF4 and express the FGF receptor, and the knockout of Fgf4 results in impaired 
differentiation to both ectoderm and mesoderm lineages
91
, suggesting that it plays a role in 
creating the heterogeneity necessary to allow exit from pluripotency and induction of lineage 
specification. The role of GSK3 inhibition is less clear, although the majority of its effect is 
believed to be related to activation of WNT signalling. Activation of WNT signalling through 
genetic perturbation of GSK3 phosphorylation-mediated β-catenin degradation showed a 
dose dependent inhibition of differentiation
92
, although other effects of GSK3 inhibition, such 
as increase in colony forming ability and c-Myc expression were not recapitulated
82
.  
Major progress in defining protocols for ESC differentiation has also been made. Whereas 
differentiation in general is easily achieved through withdrawal of maintenance factors (LIF), 
induction of particular cell identity is often a lengthy process of multistage differentiation, in 
many cases closely mimicking development and using complex components, such as stromal 
cells, which are not compatible with eventual clinical use
93
. Significant progress is being 
made, and the development of a clinically-compatible differentiation protocol for retinal 
epithelium
94
 has resulted in one of the first ever ESC-derived cell products entering clinical 
trials
95
. However, many differentiation protocols still rely on modulation of kinase or receptor 
activity with often costly peptides and proteins, often of non-human origin, although efforts 
are being made to address this
96
.  
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1.3.2 The unique ESC cell cycle and self-renewal 
Given the speed of proliferation necessary to accommodate the growth seen in the first days 
of development, it is not surprising that the architecture of ESC cell cycle is drastically 
different from that of mature cells. In vivo, cell cycle length at the developmental stages 
corresponding to ESCs has been estimated at 9.1-11.5 hours
97
, while ESC doubling times 
under standard culture conditions vary between 8 and 12 hours
98,99
, although they have been 
reported to increase to over 30 hours in serum-free culture
99
. In comparison, many mature 
cells do not proliferate, and generation times for commonly cultured mature cells, such as 
mouse embryonic fibroblasts, are reported to be around 19 hours
100
. The observed shorter 
generation time in ESCs is due to shortening of both G1 and G2 growth phases, with ~60% of 
cell cycle spent in S-phase, as opposed to ~16-20% of cycling time devoted to S-phase in 
mature cell types
98
.  
 
Figure 5: ESCs have a unique cell cycle characterized by constitutive activity of cycling and 
CDKs. Reprinted from Current topics in developmental biology, 104, Tsubouchi T, Fisher A. 
Reprogramming and the Pluripotent Stem Cell Cycle. 223-241 (2013) with permission from 
Elsevier. 
This is possible due to radically altered activity of cell-cycle machinery and absence of 
checkpoints. In somatic cells, progression through the cell cycle is tightly regulated to ensure 
conditions are right for the next phase of the cell cycle to occur.  As described above (see 
Figure 3), this is coordinated by successive activation of CDKs by their cyclin partners, 
which are sequentially expressed and promptly ubiquitinated and degraded, ensuring kinase 
activity is restricted to the proper cell cycle phase
52
.  In ESCs this oscillatory behaviour is 
lacking (see Figure 5), with constitutive CDK2, cyclin A and cyclin E activity
98
, geminin 
expression, which blocks DNA replication under normal conditions
101
, and attenuated APC/C 
oscillations
102
. The usual checkpoints that are present in the cell cycle of somatic cells are 
also absent. The restriction point is absent from ESC, where Rb is in a phosphorylated state 
throughout the cell cycle
103
. Consistent with this, serum starvation does not result in cell cycle 
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arrest
104
 indicating that mitogen signals are dispensable for ESC proliferation. p16 fails to 
inhibit the CDK6-CycD3 complex
105
  further indicating a lack of a G1/S checkpoint. 
Induction of checkpoints associated with DNA damage and resulting in p53-induced cell 
cycle arrest, leads instead to loss of pluripotency, as translocation of p53 to the nucleus 
downregulates Nanog expression in ESCs
106
. Similarly, activation of the mitotic checkpoint, 
which is functional in ESCs, does not result in apoptosis as in somatic cells
107
, a G2/M 
accumulation and impaired apoptosis were also seen upon CDK1 inhibition in human 
ESCs
108
.  
The role of this altered cell cycle architecture in pluripotency maintenance is debated, but the 
prevailing view is that a link exists. G1 length has been most discussed in this context, as 
differentiation is accompanied by G1 lengthening
109
, while reprogramming to a pluripotent 
state both requires and results in G1 shortening
110,111
. Additionally, findings that 
differentiation factors are preferentially expressed in G1
112
, and the G1/S inhibitor p27 plays 
a role in repressing Sox2 during differentiation
113
  further link cell cycle control in G1 and 
pluripotency maintenance.  In complete contradiction, it has also been reported that extension 
of G1 by exogenous expression of p21 and p27 did not compromise pluripotency under 
maintenance or differentiation conditions
114
, although the same authors later reported 
improved differentiation when G1 lengthening was induced by culture in low serum 
conditions
115
. 
1.4 THE ROLE OF IONS AND THEIR REGULATION IN EUKARYOTIC CELLS 
Whether in vivo or in vitro, cells exist in an aqueous environment which allows diffusion of 
nutrients, signalling molecules, and wastes to and from the cell, thus sustaining cellular 
metabolism.  While the cell membrane is permeable to water, it is not permeable to many of 
the molecules and ions found in the interstitial fluid. In fact, concentrations of many ions and 
metabolites inside and outside of the cell are unequal, often differing by multiple orders of 
magnitude
116
. Sodium (Na
+
) and potassium (K
+
) are the most differentially distributed 
intracellular ions, each with an over 10-fold difference in cytoplasmic and external 
concentrations. This gradient is used to drive nutrient transport
117
, regulate cell volume
118,119
, 
and in signalling, by allowing rapid changes in the cell’s electrical properties. Whether 
directly or through their downstream targets, Na
+
 and K
+
 currents influence multiple aspects 
of cellular physiology including cell division
120
 and differentiation
121
.    
In addition to Na
+
 and K
+
, concentrations of other metal ions are also tightly controlled in the 
cell. Calcium (Ca
2+
) can directly influence protein function by inducing conformational 
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changes upon binding, and is used as a messenger and as a cofactor in processes such as 
vesicular transport
122
. It has been well established as a regulator of differentiation
123
, 
apoptosis
124
, and neuronal firing
125
. The temporal dynamics of fluctuations in Ca
2+
 
concentration, and not just the absolute concentration, have also been shown to have a 
regulator role.  
Somewhat less well-understood are the regulatory functions of metals such as magnesium 
(Mg
2+
), iron (Fe
3+
), zinc (Zn
2+
), copper (Cu
2+
), and manganese (Mn
2+
). Their concentrations 
are tightly regulated in the cell and they are known to be essential cofactors for essential 
cellular processes, such as adenosine triphosphate (ATP) utilization (Mg
2+ 126
), ATP 
production in the mitochondria (Fe
3+ 127
), detoxification (Cu
2+
, Zn
2+
, and Mn
2+ 128
), and 
transcriptional regulation (Zn
2+ 129
). In fact, presence of exogenous ions, such as lithium or 
lead, can have significant effects on development and cell physiology due to competitive 
inhibition of enzymes through replacements of their endogenous ionic cofactors.  Despite 
their clear importance, study of these ions is complicated by difficulties in detection and lack 
of specificity for any eventual clinical applications. Although little is known about the 
regulation of these ions, a number of successful attempts at modulating intracellular ion 
concentrations to achieve cell fate effects by varying cell media compositions have been 
made 
130,131
, reflecting that the role of ions in cellular physiology is becoming increasingly 
appreciated. 
1.4.1 Ion channels in proliferation and differentiation 
Ion channel activity has been suggested to regulate proliferation already in the 1950’s, when 
it was observed that non-proliferative cells had lower resting membrane potential than 
proliferative cells
132
  and membrane potential varied during cell cycle progression
133
. This 
was further supported by the findings of Cone that hyperpolarization of dividing cells induced 
arrest
134
, while depolarization of even post-mitotic neurons induced their proliferation
135
. 
Since then ion channels, in particular K
+
 channels, have been linked to cell cycle progression, 
both due to their cell-cycle phase-specific expression and function
136,137
, and the ability to 
manipulate proliferation via ion channel inhibition
138-140
. Ca
2+
 channels
141
  and chloride 
channels
142
 have also been implicated in cell cycle progression in multiple cell types, as has 
the Na
+
-K
+
 ATPase, which is proposed to be responsible for G1 hyperpolarization
143
.
 
Ion channel control of stem cell proliferation has also been shown. While it may not be as 
surprising for NSPCs, which although not electrically active mature to be electrically active 
cells, it is even the case for ESCs. Regulation of ESC proliferation by ligand-gated ion 
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channels has previously been reported
144
, with activation of the GABAA receptor carrying a 
chloride current resulting in accumulation of cells in the S phase. Similarly, it induced 
quiescence in NSPCs
145
. Block of L- and T-type Ca
2+
 channels was shown to attenuate ESC 
proliferation, with T-type channel block resulting in an accumulation of cells in G1 and G2/M 
cell cycle phases and differentiation
146
.  L-type channel block caused a reduction in BrdU 
incorporation and cell numbers
147
, which is compatible with an induction of differentiation 
reported for these channels
148
. Similarly, block of tetraethylammonium (TEA)-sensitive K
+
 
channels induced an accumulation of ESCs in G0/G1 and compromised pluripotency
149
, 
while block of the hyperpolarization-activated cyclic nucleotide-gated (HCN) K
+
 channel 
family resulted in S-phase accumulation of ESCs with uncharacterized effects on stem cell 
fate
150
.  
Recent publications have suggested that modulation of cellular electric properties can be an 
instructive factor in stem cell differentiation: optogenetic stimulation improved neural and 
neuronal differentiation of ESCs
151
, activation of Ca
2+
-activated potassium channels resulted 
in enrichment in cardiac pacemaker cells
152
, and block of L-type Ca
2+
 channels, known to 
have an instructive effects on NSPC proliferation and differentiation
153
, was shown to restrict 
ESC differentiation to non-mesodermal lineages
148
. Curiously, when L-type Ca
2+
  channels 
were blocked with a different compound, differentiation to cardiomyocytes, a mesodermal 
lineage, was improved
154
, underlining the importance of further characterization of ion 
current effects on stem cell fate. 
1.4.2 Lithium 
Lithium is a metal that is already well established in the clinic. First introduced by John Cade 
for the treatment of manic patients in 1949
155
, it has been a cornerstone of therapy and the 
target of extensive study, as deciphering its mechanism of action could be key to 
understanding psychosis. Its effects are however not limited to behaviour. Patients treated 
with lithium and responding to treatment were shown to have increased grey matter volume 
in the prefrontal cortex, which was not present in the non-responders
156
. In line with this, 
lithium enhanced proliferation of hippocampal neural progenitor cells in the mouse both 
under homeostatic
157,158
 and radiation injury conditions
35
. Outside the brain, lithium treatment 
is known to increase neutrophil and reticulocyte counts
159
, and has been shown to affect 
osteoblastic differentiation in vitro
160
. Interestingly, while reportedly only resulting in a mild 
increase in heart defects in humans
161,162
, lithium can severely dysregulate embryonic 
 24 
development, resulting in excessive endomesoderm formation in Xenopus laevis
163
, and 
defective patterning in zebrafish and mouse embryos
164,165
.   
Despite many known effects and many proposed modes of action with experimental support, 
there is no consensus on which molecular pathway is responsible for mediating lithium 
action. The most discussed pathways are the inositol and GSK3β pathways. Lithium is 
reported to inhibit inositol monophosphatase (IMPase ) with an inhibitory constant 
(concentration achieving 50% inhibition, Ki) of 0.8mM
166
 and inositol polyphosphate 1-
phosphotase (IPPase) with Ki=0.3mM
167
, two enzymes critical in inositol metabolism, by 
replacing their cofactor Mg
2+
. This results in reduced availability of the second messenger 
inositol-1,4,5 triphosphate (IP3) which is a major mediator of extracellular signals and lies 
upstream of protein kinase C (PKC). Alternatively, lithium has been reported to inhibit the 
transcription of the sodium/myo-inositol cotransporter 1 (SMIT1), a Na
+
 coupled inositol 
transporter
168,169
, also resulting in lower inositol availability. The fact that levels of inositol in 
vivo are not affected at therapeutic lithium concentrations argues against this as the major 
pathway through which lithium acts.  In the GSK3β pathway, lithium inhibits GSK3 β, also 
by competing with magnesium
170
, resulting in accumulation of β-catenin and dysregulation of 
WNT signalling, which is a key regulator of multiple cellular processes, including patterning 
during development and cell fate.  Conflicting reports regarding behaviour of GSK3β 
knockout mice and the fact that lithium-induced mouse embryogenesis defects were not 
mediated by WNT signalling argues against GSK3β-WNT axis as the major effector of 
lithium action.    
Some less commonly discussed targets of lithium have also been described, many in 
metabolic pathways. Bisphosphate 3'-nucleotidase 1 (BMPT1), an enzyme in the sulfate 
metabolism pathway which compromised protein synthesis when knocked out
171
, is inhibited 
by lithium with Ki of 0.153 mM
172
. In the glycolysis and glycogenesis pathway, fructose 1,6-
bisphosphatase
173
 has been suggested to be inhibited, while glucose 1,6-biphosphate 
synthase
171
 enzymatic activity was greatly slowed down by lithium. In line with this, earlier 
work showed that rate constants for reactions catalyzed by  lithium-bound 
phosphoglucomutase was 4x10
8
 times slower than when the enzyme is bound to its usual 
cofactor magnesium
174
. In cell systems, treatment with lithium has been linked to inhibited 
glycogen synthesis in astrocytes
175
, and long term lithium treatment in vivo resulted in 
reduced glycogen content in rat livers
176
 and perturbed brain metabolite concentrations when 
examined over the 8 hours post injection
177
.  
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1.4.3 Hyperpolarization-activated cyclic nucleotide-gated (HCN) family 
channels 
Electrochemical changes on a cellular level are essential for cardiac pacemaking, muscle 
contraction, and neural processes. This is accomplished by the concerted action of gated ion 
channels, which taking advantage of the electrochemical gradients of some ion species 
existing between the cytoplasm and interstitial fluid, facilitate rapid and drastic changes in the 
electrical properties of cells. The heart is perhaps the best known example of this. Opening of 
voltage-gated sodium channels causes rapid Na
+
 influx and cell depolarization, which 
deactivates the channels and activates other voltage gated channels sensitive to 
depolarization. Influx of Ca
2+
 and efflux of K
+
 through these channels restore membrane 
potential to below activating voltage of the Na
+
 channels that initiated the event, giving time 
for Na
+
-Ca
2+
 exchanger (NCX) and the Na
+
-K
+
 ATPase to restore the ion balance. The 
current that then drives partial depolarization allowing the entire event to happen again, is the 
“funny” current (If, also known as Ih) carried by HCN4, one of the members of the HCN 
channels family
178
.   
Activation at hyperpolarized potentials is a unique feature of this channel family, which 
consists of four channel isoforms, activating at different voltages and differentially modulated 
by cyclic adenosine monophosphate (cAMP)
179
. The channels are permeable to Na
+
 and K
+
 
and to a much lesser degree to Ca
2+
, but generally conduct inward Na
+ 
currents due to the 
electrochemical gradient of the ion. The four isoforms have different tissue distribution, with 
HCN1 and HCN2, which have the fastest kinetics, expressed in the CNS and the heart, while 
HCN3 and HCN4 are expressed in selected regions of the heart and CNS, as well as in other 
organs, such as the lung, liver, and muscle
180
. Interestingly, the channels assemble into 
tetramers, which can be composed of multiple isoforms, giving rise to a wide range of 
conductance and activation properties. Channel function is also modulated by trafficking
181-
183
 , auxiliary subunits
184,185
, phosphatidylinositol 4,5-bisphosphate (PIP2)
186
, and G-protein 
coupled receptors
187
. 
In addition to cardiac rhythm generation, HCN function is implicated in many neuronal 
functions, ranging from mood regulation to regulation of circadian pacemaking and 
learning
188
. In non-excitatory cells, a pro-apoptotic effect of HCN2 has been described
189
, and 
the channels have been reported to regulate the proliferation of ESCs
150
. The channels can be 
blocked by cesium chloride (CsCl), and due to significant interest in modulation of HCNs in 
epilepsy and cardiac arrhythmias, a number of small molecule inhibitors have been 
developed. ZD7288 is one of the most specific and commonly used HCN inhibitors
190,191
, 
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although this has recently been put into question
192
. An elegant way of targeting the brain 
while avoiding cardiac effects is being explored by developing drugs targeting the interaction 
of HCNs with their auxiliary subunit TRIP8b
193
 which is not expressed in the heart. 
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2 AIMS 
The aim of this thesis was to investigate the action of ionic modulators on stem cell state. 
More specifically, the following three sub-aims were defined: 
I. For lithium chloride, an ionic modulator with well-investigated non-ionic downstream 
effector pathways, to investigate the proliferative and anti- apoptotic effects on in 
vitro cultured juvenile mouse neural stem progenitor cells in the context of ionizing 
radiation.  
II. For ZD7288, an inhibitor of the hyperpolarization-activated cyclic nucleotide-gated 
(HCN) channel family, to investigate the effects on stem cell state in a well-defined, 
robust, in vitro stem cell system (mouse embryonic stem cells). 
III. To investigate effects of HCN inhibition on the proliferative state of mouse neural 
stem progenitor cells and identify potential downstream effector pathways underlying 
cell state effects.        
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3 MATERIALS AND METHODS 
Please refer to the materials and methods sections of the included papers for detailed 
descriptions of experimental procedures, techniques, and reagents used.   
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4 RESULTS AND DISCUSSION 
4.1 PAPER I: LITHIUM INCREASES PROLIFERATION OF HIPPOCAMPAL 
NEURAL STEM PROGENITOR CELLS AND RESCUES IRRADIATION-
INDUCED CELL CYCLE ARREST IN VITRO 
Cancer therapy involving irradiation of brain tissue in juvenile patients is associated with 
reduced cognitive performance later in life. One of the mechanisms proposed to mediate this 
effect is irreparable damage to the neural stem progenitor cells (NSPCs) in the developing 
brain, which are then not able to sustain proper development. Lithium chloride (LiCl), an 
antipsychotic drug with a long history of use in the clinic has been suggested to be a 
promising candidate for neuroprotection. This paper investigates the effects of lithium on 
mouse NSPCs in vitro, focusing on the cell physiology and outcomes following drug 
treatment and ionizing radiation (IR) exposure. To reflect the clinically relevant population, 
juvenile (post-natal day 8) mice were used for NSPC preparation. The SGZ, which is the site 
responsible for cognitive development in humans and likely affected in cancer patients, was 
chosen as the anatomical site from which NSPCs were isolated. 
4.1.1 Lithium has a concentration-dependent effect on NSPC proliferation 
To characterise the effects of LiCl on NSPCs, cells  were adapted to in vitro culture by 
neurosphere formation for 4 days, following which they were dissociated to a single cell 
suspension and exposed to 0,1, or 3 mM LiCl in standard media.  
Analysis of sphere size 24 and 48 hours following treatment initiation found increased sphere 
volume in 3 mM LiCl treated cultures as compared to control at both time points (increases of 
≈3.7 fold and ≈3.2 fold, respectively), reflecting larger cell numbers. 1 mM LiCl treated 
cultures also showed a trend toward increased sphere volume.  While this could be due to 
altered rates of cell death, levels of both apoptosis and necrosis were found to be similar in 3 
mM LiCl treated and control cells. To investigate possible cell cycle effects, cell cycle 
distribution of treated and control cells was examined by flow cytometry analysis of DNA 
content at 12, 24, 48, 72, and 96 hours post treatment initiation. While there was no effect at 
12 hours, the G1 fraction was reduced while the S fraction was increased in the cultures 
treated with 3 mM LiCl at all later time points. The G2/M fraction in LiCl treated cells was 
reduced compared to control at 24 hours, but increased at 48 hours following treatment. 
Similar trends were seen in 1 mM LiCl treated cultures. S-phase findings were confirmed by 
increased bromdeoxiuridin (BrdU) incorporation at 48 hours. Unaltered frequencies of cells 
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staining positive for glial (GFAP) and neuronal (MAP2) markers indicate that LiCl treatment 
was not associated with differentiation. 
These findings support the previous reports that lithium increases proliferation of NSPCs, 
where GSK3β inhibition causing activation of WNT signalling was implicated in the 
response. They are also in line with reports of lithium-induced proliferation in other cell 
types. The observed changes in the G1 fraction may reflect altered cell cycle dynamics and a 
shorter G1, activation of previously quiescent cells, or some combination of these two effects.  
4.1.2 Lithium protects NSPCs from irradiation, recruits them into 
proliferation following IR-induced G1 arrest and reduces DNA damage, 
but does not affect apoptosis.  
To investigate potential neuroprotective effects of LiCl, NSPCs grown in vitro were treated 
with 0, 1, or 3 mM LiCl for 12 hours, following which cultures were exposed to 0 or 3.5 Gy 
of IR and allowed to form spheres in the same medium. IR treated cells formed smaller 
spheres than sham irradiated cells, with effects of radiation clear at all time points analysed 
(up to 72 hours) and significantly more drastic in the cells that were not pre-treated with 
lithium. While sphere volume in non-treated irradiated cells was ≈7.5 fold smaller than in 
sham irradiated cells, the reduction was only ≈2 fold in the cells that were pre-treated with 3 
mM LiCl. Similar effects were observed at 24 hours and with lower (1 mM) LiCl 
concentration.  
BrdU incorporation rates indicated that proliferation after irradiation remained higher in the 
3mM LiCl treated than untreated cells, although it was lower than in 3mM LiCl treated sham 
irradiated cells. Interestingly, the proliferative differences were more pronounced in the 
irradiated cultures due to very low proliferation in the non-LiCl treated group. In fact, 
irradiation induced a significant G1 and G2 accumulation in both pre-treated and non-treated 
culture at the expense of the S-phase fractions. LiCl-treated cells recovered quicker, with 
more cells entering S than in the control cultures already at 24 hours after irradiation. To test 
if reduced DNA damage could underlie the recovery, levels of γ-H2AX staining, a marker of 
DNA damage, were examined 30 min after irradiation in treated and control cells. 3 mM LiCl 
treated cells were found to have on average 13 % lower staining intensity, suggesting a more 
limited extent of DNA damage.  Finally, effect of treatment on cell death was examined. 
Staining for Annexin-V, a marker of apoptosis, and quantifying the subG1 DNA fraction 
indicated that LiCl treatment did not affect apoptosis or necrotic cell death. 
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Although LiCl treatment did not prevent IR-induced cell death, as was suggested 
previously
194
, it did reduce IR-induced DNA damage, or at least the extent of response. This 
did not abolish, but rather attenuated the G1 accumulation seen after irradiation in the LiCl 
pretreated cells, which returned to proliferation faster than the non-pretreated cells. It is 
possible that this is due to lower rates of DNA damage, faster DNA repair, or more 
worryingly, leaky DNA damage checkpoints. It is interesting that the G2/M fraction in the 
LiCl pretreated cells remained elevated for up to 72 hours following irradiation. A potential 
explanation of this could be differential activation of DNA damage pathways in cells at 
different stages of the cells cycle, or impaired clearing of γ-H2AX foci due to reduced protein 
kinase B (Akt) activation
195
 following lithium effects on the inositol pathway.      
In summary, we found that LiCl induced NSPC proliferation under homeostatic conditions, 
and attenuated IR-induced DNA damage response and G0/G1 stalling. Although treatment 
did not reduce levels of cell death, cell numbers in treated cultures were increased due to 
increased proliferation.  
4.2 PAPER II: ZD7288, A BLOCKER OF THE HCN CHANNEL FAMILY, 
INCREASES DOUBLING TIME OF MOUSE EMBRYONIC STEM CELLS 
AND MODULATES DIFFERENTIATION OUTCOMES IN A CONTEXT-
DEPENDENT MANNER 
The unique cell cycle properties of pluripotent stem cells have been linked to their identity 
and postulated to be essential for pluripotency maintenance. ZD7288, an inhibitor of the 
HCN channel family, has previously been reported to modulate cell cycle progression in 
mouse embryonic stem cells (ESCs), however the effects of this compound and the cell cycle 
perturbation it caused on cell fate were not described. This paper investigates the cell cycle 
dynamics and cell fate of mouse ESCs treated with ZD7288.  
4.2.1 ZD7288, an HCN channel blocker, reduced ESC proliferation by 
increasing doubling time due to extended G1 and S phases 
ESCs cultured in maintenance media with the addition of ZD7288 were found to be 
significantly fewer after 4 days of culture, with a reduction in cell number of over 50% as 
compared to control culture conditions, accompanied by only a disproportionally small 
reduction in viability, in line with the previously described action of the compound
150
. 
Similarly, cells plated at subclonal densities and cultured in the presence of the compound 
formed significantly smaller colonies (27 vs 44 cells per colony in treated and control cells, 
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respectively). Reduced cell numbers could be explained by fewer proliferating cells or longer 
cell cycle. G0 is usually absent from ESCs, but to ensure that all cells were in active cell 
cycle, cells were stained for KI-67, a marker of active proliferation. As expected, no 
differences were observed, suggesting that the cell cycle was longer in ZD7288 treated cells. 
Based on these cell number observations, doubling time for treated cultures was calculated to 
be ≈37 hours, as compared to ≈28 hours for control cells, in line with previous reports99.   
To examine what accounted for the increased cell cycle length, we performed DNA content 
analysis using flow cytometry. This showed a significant increase in the fraction of cell in S-
phase (37.6 % in control, 41.8 % in treated) and a corresponding decrease in G2/M phase 
(28.3 % in control, 23.4 % in treated) in the treated cultures.  Taken together with the 
calculated doubling time, this corresponds to an increase in the length of G1 and S phases in 
response to ZD7288 treatment.  This was in contrast to what had previously been reported. 
Previous report by Lau et al
150
  indicated an accumulation in S-phase with a compensatory 
decrease in the G1 fraction, indicating an increase in the length of S-phase only. Interestingly, 
the cell cycle length in the previous publication was much shorter than in the present one, 
possibly due to difference in culture conditions. Lau et al
150
 used serum-based, whereas this 
study used serum-free media, and it has previously been reported that ESC doubling time 
varied between 13 and 34 hours depending on media formulation, with serum-free medias 
resulting in longer doubling times. 
4.2.2 DNA replication is altered in ZD7288 treated cells  
Surprisingly, the number of 5-ethynyl-2´-deoxyuridine (EdU) incorporating cells, a marker of 
cells in S-phase, appeared to be lower in treated cultures when examined using flow 
cytometry. This was puzzling because the number of S-phase cells was increased in treated 
cultures based on DNA content quantification, prompting us to take a closer look at the at 
EdU incorporation pattern. EdU staining pattern was distinctly different in the treated cells, 
which formed a single wide peak, instead of the two peaks corresponding to positive and 
negative cells usually seen, and observed in the control.  
Potential causes of this alteration could be intra-S phase stalling, reduced DNA replication, or 
reduced availability of the EdU nucleotide. To investigate the possibility of intra-S-phase 
stalling, cells were staged as “early” or “late” S-phase based on EdU incorporation pattern 
following visualization using confocal microscopy. The fraction of “early” phase cells was 
similar in both conditions (55.7 % in control and 53.3 % in treated culture), suggesting 
altered EdU availability or slower DNA replication, which would be in line with the observed 
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prolonged S-phase transit time. It is possible that the two proposed scenarios are linked, with 
reduced nucleoside availability hampering replication. Alternatively, ion concentrations are 
known to affect DNA tertiary and quaternary structure, altered sodium or potassium 
concentrations due to HCN inhibition could induce structural changes attenuating replication 
speed. Finally, DNA replication speed varies during S-phase
196
, and the observed effect may 
be related to modulation of a mechanism involved in DNA replication speed regulation. 
4.2.3 Treatment with ZD7288 decreases colony formation frequency but 
does not alter expression of the core pluripotency genes and effects 
cell differentiation in a context dependent manner 
 To test the effects of cell cycle perturbation on pluripotency, cells were plated at subclonal 
density to test clonogenicity and self-renewal. The number of colonies formed per well was 
much lower in the treated condition, and more colonies had rough edges, which could be a 
sign of differentiation. To test this, cells were stained for the various markers of pluripotency 
(SSEA1, OCT3/4, SOX2, NANOG, and ALP activity), with no significant changes detected.  
Similarly, no changes in pluripotency marker expression were detected on an RNA level. To 
functionally test maintenance of pluripotency in ZD7288 treated cultures, treated cells were 
re-plated and both colony formation rates and colony morphology were restored to control 
levels. A possible explanation for the observed effect is altered attachment/cytoskeletal 
dynamics, which could affect both the propensity of the cells to attach and form colonies and 
cellular morphology on colony borders.  
To functionally test the effects of ZD7288 on the other cardinal stem cell property – 
differentiation, ESCs were induced to differentiate either spontaneously in fetal bovine serum 
(FBS) –containing media with LIF withdrawal, or toward the neural lineage as per defined 
serum-free protocol. Spontaneous differentiation was potentiated by ZD7288 addition, with 
more pronounced downregulation of the pluripotency markers and upregulation of most 
lineage markers. Surprisingly, neural differentiation did not benefit from ZD7288 addition, 
with similar levels of expression of most pluripotency factors in control and treated cells, and 
a less efficient induction of 2 of the 3 ectoderm markers tested. These findings suggest that 
the action of ZD7288 in differentiation is context dependent. This is rather similar to the 
difference in cell cycle effects between the previous and current reports. Intriguingly, one of 
the most striking differences is also similar – serum-containing media. Although the 
underlying mechanisms of these differences are unclear, this work adds to the weight of 
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evidence that extending G1 does not necessarily result in differentiation, at least not if the 
G1-S ratio is maintained
197
. 
In summary, we found that ZD7288, an inhibitor of the HCN channel family, reduced ESC 
proliferation by extending G1 and S residence time. This did not compromise cell identity, 
with treated cell maintaining pluripotency and the ability to differentiate to all lineages. 
Differentiation in FBS-containing media was facilitated by the compound, while directed 
differentiation to neuroectoderm in defined media was less efficient in its presence.  
4.3 PAPER III: HYPERPOLARIZATION-ACTIVATED CYCLIC NUCLEOTIDE-
GATED CHANNELS MODULATE ACTIVE PROLIFERATION AND 
METABOLISM, AND MAINTAIN MOLECULAR CLOCK OSCILLATIONS IN 
ADULT MOUSE NEURAL STEM PROGENITOR CELLS 
Data from recent sequencing studies attempting to define genes specific to the activated and 
quiescent stem cell states have indicated that a number of ion channels are differentially 
expressed in the two pools, with members of the HCN family on the list. Taken together with 
the established fact that voltage gated potassium channels are involved in cell cycle 
regulation, and data from other stem cells systems, including Paper II above, this work set out 
to investigate a potential role for HCN family channels in adult mouse NSPC proliferation.  
4.3.1 HCN2 and 3 are expressed throughout the NSPC hierarchy with their 
function restricted to the proliferative (S and G2/M) phases 
Gene expression analysis with qRT-PCR indicated that Hcn2 and Hcn3 were expressed in 
both bulk primary SVZ NSPCs, and in all populations of NSPCs sorted according to 
GFAP::GFP intensity, believed to correspond to different levels in the NSPC differentiation 
hierarchy, including type B and C cells. This was promising, as HCN3 was the isoform 
previously reported to modulate ESC proliferation, confirmed in paper II, and was identified 
as part of the quiescent stem cell signature in data from Codega et al
198
.  While expression of 
HCN3 was not confirmed on a protein level due to technical limitations, HCN2 co-stained 
BrdU+/SOX2+ NSPCs in tissue sections from the SVZ and SGZ.  To further verify channel 
expression, function was assessed with electrophysiology. The typical hyperpolarization-
activated current (Ih), sensitive to the specific blocker ZD7288, could be recorded from some, 
but not all NSPCs. 
To investigate the basis for non-uniform presence of Ih, cells were cell-cycle sorted based on 
DNA content. This showed that while no cells in the G0/G1 cell cycle fraction carried the 
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current, the current was present in many S, and the majority of G2/M cells. Correspondingly, 
HCN2 staining intensity was found to be higher in those cell cycle phases as ascertained by 
flow cytometry, and differential channel localization was observed in the three cell cycle 
phases by confocal microscopy. The association of HCN function with the proliferative 
phases further supported the hypothesis that the channel could be implicated in the regulation 
of proliferation.  
4.3.2 Inhibition of HCN channel activity attenuated NSPC proliferation due to 
a reversible G0/G1 block in vitro and its effects extend in vivo 
Culture of primary SVZ NSPCs in the presence of ZD7288, an HCN channel inhibitor, 
resulted in smaller neurosphere size, while block of HCN function with different 
concentrations of its inhibitors ZD7288, Zatebradine, or CsCl resulted in lower SVZ NSPC 
number as determined by a viability assay.  To ensure the difference in cell numbers was not 
due to cell death, as HCN has been reported to regulate apoptosis
189
, levels of activated 
caspase-3 and the subG1 fraction of cell cycle were quantified. No significant induction of 
cell death was observed. Moreover, EdU incorporation was significantly reduced (by 46%) in 
treated cells 24 hours after treatment initiation.  The proliferative effects were confirmed on a 
genetic level with si- and shRNA. Rather conflictingly, siRNA showed that HCN2 but not 
HCN3 knockdown reduced cell numbers, while shRNA, showed that knockdown of either 
gene was sufficient to see a reduction in proliferating cells. This could be due to different 
potency of knockdown, but regardless, confirmed the expectation that HCN activity is 
involved in regulation of NSPC proliferation.  
To further investigate the effect of HCN inhibition on the cell cycle, DNA content analysis of 
treated and untreated cells was performed, indicating an increase in G0/G1 cell cycle fraction 
accompanied by a reduction in the S and G2/M. To further identify whether it was G0 or G1 
that was affected, cells were stained for KI-67, which showed an increase in cells no longer in 
active proliferation, as indicated by loss of KI-67 marker expression. This was further 
supported by increased survival of ZD7288 treated NSPCs upon long term (48 hours) 
exposure to the genotoxic agent arabinofuranosyl cytidine (Ara-C), and the full reversibility 
of the induced proliferative block upon washout. The reversibility of the proliferative effect 
distinguished the observed block as quiescence, as opposed to senescence.   
Importantly, similar effects on proliferation (reduction in proliferation by BrdU 
incorporation, phospho-histone 3 (a marker of M-phase) expression, and KI-67 expression) 
were seen in vivo in both SVZ and SGZ when animals were injected with 4mg/kg of ZD7288. 
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This was not accompanied by induction of apoptosis, with onset of action observed at 24 
hours and complete attenuation of the effect at 72 hours, further supporting reversibility.  
4.3.3 Transcriptome analysis identified alterations in expression of cell 
cycle regulators, metabolic enzymes, and members of the molecular 
clock in treated cells, while NSPC identify marker expression was not 
altered  
Transcriptome analysis confirmed that treated cells were not undergoing differentiation, as 
expression of key NSPC regulatory genes Sox2, Pax6 and Msi1 was similar in treated and 
untreated cells, and expression of differentiation genes was not induced by treatment. 
Markers of quiescence and activation, on the other hand, were altered. Nestin and Ascl1, both 
implicated in activation and stem cell proliferation, were downregulated on an RNA level, 
while western blot for EGFR indicated that the receptor was downregulated on a protein 
level. Inhibition of proliferation was further confirmed by reduced expression of many 
positive cell cycle regulators in treated cells, while some negative regulators of proliferation 
were upregulated. p21 and p27 canonical inducers of cell cycle arrest, were upregulated on an 
RNA, but not protein level, suggesting a novel mechanism for induction of quiescence in 
response to HCN inhibition. 
Gene Ontology (GO) term enrichment analysis of differentially expressed genes identified 
metabolism as one of the major gene categories altered in treated cells. Enzymes involved in 
glycolysis were strongly downregulated. To complement this analysis and look at metabolism 
more functionally, we analyzed metabolite abundance. Levels of glycolysis intermediates, 
lactate, and amino acids were found to be significantly altered, confirming a metabolic 
perturbation as either the mediator or a consequence of the effects of HCN inhibition.   
When a more narrow approach was taken GO enrichment analysis was run on genes shared 
between the quiescence signature published by Codega et al
198
 and those altered in response 
to ZD7288. “Rhythmic processes”, containing many genes known to be components of the 
molecular clock network (Per1, Per2, Cry1, Cry2, Nr1d1 and Nr1d2 (Rev-Erb-α and ), 
Timeless and Tipin),  was the most significantly enriched term. To test functional significance 
of the observed change, luminescence from Per2-driven luciferase was recorded in adherent 
NSPCs and SVZ explants with and without ZD7288 in the media. In line with observations 
of deregulation on the transcriptional level, clock oscillations were abolished upon HCN 
inhibition.  In light of the previous reports of clock function regulating proliferation in other 
stem cell systems
199,200
, we tested whether ZD7288 effect could be phenocopied by activation 
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of Rev-Erb- α, the most upregulated component of the clock network identified in our dataset. 
Treatment of NSPCs with the Rev-Erb- α agonist SR9009 resulted in reduced proliferation, 
suggesting its involvement in mediating the effect of HCN inhibition. Interestingly, 
hippocampus hyperproliferation was reported in Rev-Erb- α knockout animals201, supporting 
its function as a regulator of proliferation in NSPCs. It has also been reported to be inhibited 
by lithium
202
, representing an alternative pathway for proliferative increase seen in paper I. 
Although it is not clear if or how the observed changes in metabolism and the molecular 
clock are related, recent publications have reported metabolic perturbations in the kidneys of 
clock-null animals
203
. 
4.3.4 Pre-treatment of juvenile mice with ZD7288 and a neuroprotective 
effect, reducing the deleterious effects of ionizing radiation. 
Following up on work in paper I, neuroprotective potential of HCN blockade was tested in 
an animal model of ionizing radiation (IR)-induced NSPC damage. Juvenile animals (post-
natal day 8) were treated with ZD7288 (8 mg/kg) 24 hours prior to exposure to 2Gy of IR. 
Animals were sacrificed 6 hours following exposure and levels of proliferation and cell death 
were examined in the neurogenic areas (SGZ and SVZ). The levels of apoptosis as seen by 
activated caspase-3 staining were significantly reduced, and proliferation as measured by 
BrdU incorporation was similar in treated and untreated animals. No cell cycle analysis was 
performed, as in paper I, to assess potential additional stalling of cells in G0/G1, but similar 
proliferation rates in both irradiated and non-irradiated animals suggest that proliferation was 
not affected by IR, possibly due to the fact that the most sensitive cells were in proliferative 
arrest due to ZD7288 treatment, and thus protected from IR damage and the apoptosis that 
would have followed. An alternative explanation of HCN inhibitor action could be related to 
calcium influx-induced apoptosis, in which HCN2 was previously implicated. 
To test whether there may be a therapeutic window with HCN inhibition, and a similar 
protective effect would not be observed for cancer cells, 17 patient-derived cancer stem cell 
lines were tested for growth response following culture in media containing 0-49 µM 
ZD2788. Across all lines there was no change in viability signal to any of the tested inhibitor 
concentrations, suggesting that HCN has no proliferative effect in cancer stem cells. As the 
cell line tested were of human origin, while all other work had been done on murine cells, to 
ensure the observed lack of effect was not due to species differences, proliferation kinetics in 
response to ZD7288 treatment were tested in human fetal neural stem cells (hfNSCs) and 
human glioma-initiating cancer stem cells (giCSCs). Confirming the viability test results, the 
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number of EdU positive giCSCs did not change in response to ZD7288, while proliferation of 
hfNSCs was  inhibited resulting in fewer EdU incorporating cells, as observed earlier in 
mouse NSPCs. The differential response of cancer and tissue stem cells to HCN inhibition 
could reflect abnormal cell cycle regulation in cancer cells
204
, but also disrupted clock 
function, which has been reported previously
205
. Finally, alterations in metabolism, a 
hallmark of cancer
206
, is also a possible explanation of observed differences. 
In summary, HCN2 and HCN3 are expressed in mouse NSPCs with function restricted to the 
S and G2/M phases. Their inhibition inhibited proliferation inducing a reversible G0/G1 
accumulation accompanied by changes in markers of quiescence/activation and cell cycle, but 
not stem cell identity. This was accompanied by downregulation of glycolysis and changes in 
metabolite levels, as well as abolition of molecular clock oscillations due to upregulation of 
negative clock components. An agonist of the peripheral clock component Rev-erb-α could 
mimic the proliferative effects of HCN inhibition. This effect could be confirmed in both 
proliferative regions in vivo, and resulted in reduced cell death in juvenile animals pre-treated 
with ZD7288 prior to IR exposure. 
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5 CONCLUSION AND FUTURE DIRECTIONS 
The work in this thesis showed that: 
I. Lithium induces proliferation of juvenile mouse NSPCs in vitro, and although it 
does not reduce apoptosis, it protects them from IR-induced DNA damage, and 
induces their return to proliferation following G1 block 
II. Treatment of mouse embryonic stem cells with the HCN blocker ZD7288 
attenuates their proliferation by extending their cell cycle, specifically in the G1 
and S phases. Treatment does not compromise pluripotency under maintenance 
conditions, but can facilitate differentiation in a context-dependent manner. 
III. HCN2 and HCN3 are expressed in NSPCs and functional in the S and G2/M 
phases. Block of their activity reduces proliferation in vivo and in vitro by 
inducing a reversible cell cycle block in the G0/G1 phase, which exhibits many 
features of quiescence: reducing glycolytic metabolism, downregulating markers 
of activation, and maintenance of NSPC identity. Ih current block also disrupts 
oscillations of the molecular clock, with modulation of the clock component Rev-
erb-α having similar effects on proliferation. 
IV. HCN activity can protect NSPCs from genotoxic stress both in vitro and in vivo, 
and attenuates IR-induced apoptosis in vivo. HCN inhibition may have the 
potential to be developed into a neuroprotective therapy for pediatric cancer 
patients.    
Additional work exploring the mechanisms behind these finding and investigating their 
potential translation to the clinic is needed. The work presented here makes a case for 
modulation of ion-dependent processes as an in-point for cell state regulation. Modulation of 
ion availability as a co-factor (in the case of lithium effects) or ion trafficking (in the case of 
HCN inhibition) have both been shown to be viable strategies for regulation, although the 
downstream mechanisms and exact targets of each intervention remain to be elucidated. An 
interesting area of overlap is metabolism, which is regulated in a circadian manner both on a 
whole-organism and on the cell level
207
, and is known to regulate stem cell dynamics, both in 
adult stem cell systems
208,209
 and in the embryo through diapause and reprogramming
210,211
.  
It is however unclear how the metabolic and circadian regulatory systems relate to each other 
and proliferation – are these parallel processes that can exert proliferative control? Is one 
process subservient to the other? Are perturbations in one system just a side effect of the 
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deregulation of the other? The effect observed in ESCs in paper II, if mediated in a similar 
fashion to the NSPC effect in paper III, would put metabolism at the top of the hierarchy, 
and circadian perturbations as a side effect, because ESCs lack a circadian clock
212
. It is 
unclear how well this would generalize to somatic cells, as ESCs also lack conventional cell 
cycle control. To more appropriately address this question, it would be interesting to test how 
the effects of HCN inhibition observed in paper III would change in BMAL1-deficient mice, 
which lack circadian rhythmicity
213
, but not the usual somatic cell cycle machinery. To more 
closely examine the interaction of HCN-inhibition, metabolism, and proliferation, it would be 
interesting to follow up the work in paper II on proliferative slow down of ESCs with further 
experiments looking at metabolic effects in that cell system. ESCs are a relatively 
homogenous and robust cell system, while still relevant in a developmental context, making 
them a good platform for research into fundamentals of cellular physiology.  
This thesis also investigated two very different approaches to neuroprotection – temporary 
attenuation of proliferation (paper III) and a combination of DNA damage protection and 
induction of proliferation to overcome cell loss due to IR treatment (paper I). In addition to 
developing compounds and techniques for more precise delivery of active compounds to 
injury site, this work could be followed-up by investigations into how these two interventions 
may be combined to improve outcomes. Pre-treatment with an HCN inhibitor in combination 
with acute or follow-up treatment with lithium may be a worthwhile approach to 
neuroprotection, taking advantage of both strategies to overcome IR-induced damage. Since 
significant additional work would be needed to characterize such a regiment, lithium is likely 
a more promising first approach for clinical tests of neuroprotection due to its fairly well 
understood toxicity profile. However, long-term implications of lithium use should first be 
more thoroughly investigated. Deregulation of proliferation can lead to tumorigenicity, 
especially in combination with genotoxicity and stress, which NSPCs face following IR 
treatment. Ideally, development of therapy should be guided by mechanistic insights into the 
mode of action of both lithium and HCN inhibition, until then, the empirical approach should 
not be overlooked. 
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